The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Level Of Market Value Growth Is Predicted For The Fluorescent In Situ Hybridization Probe Market From 2026 To 2030?
The market for fluorescent in situ hybridization probes has experienced strong growth in recent years. It is projected to increase from $1.68 billion in 2025 to $1.8 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.1%. This historical expansion can be attributed to factors such as the limited availability of fluorescent probes, the reliance on conventional single-color FISH, a growing awareness of genetic diagnostics, increased research funding in molecular biology, and the adoption of fluorescence microscopy.
The fluorescent in situ hybridization probe market size is projected to experience substantial growth in the upcoming years. It is anticipated to expand to $2.39 billion by 2030, achieving a compound annual growth rate (CAGR) of 7.3%. This projected growth can be ascribed to several factors, including the evolution of multiplex and combinatorial barcoded probes, increasing applications within personalized medicine, the expansion of pharmaceutical and biotechnology research, stricter regulatory compliance and standardization, and the integration with AI-driven image analysis and data analytics. Significant trends anticipated during the forecast period encompass a rising adoption of FISH probes in clinical diagnostics, the broadening of multiplex and high-throughput screening techniques, their increasing utilization in genetic and agricultural research, integration with advanced imaging and analysis tools, and a concentrated focus on custom probe development for personalized medicine.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27289&type=smp
Which Primary Drivers Are Impacting The Fluorescent In Situ Hybridization Probe Market Growth?
The future expansion of the fluorescent in situ hybridization probe market is expected to be propelled by the increasing adoption of personalized medicine. This medical model customizes treatments and healthcare based on a person’s genetic and lifestyle information to address their specific needs. The growing embrace of personalized medicine is due to individuals favoring health technologies that offer real-time monitoring and treatment plans tailored to their unique biology. Fluorescent in situ hybridization (FISH) probes support personalized medicine by enabling precise detection of genetic abnormalities at the chromosomal level, thereby guiding individualized therapeutic decisions based on an individual’s unique genetic profile. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, significantly up from six in 2022. Thus, the increasing adoption of personalized medicine is a key driver for the growth of the fluorescent in situ hybridization probe market.
How Is The Fluorescent In Situ Hybridization Probe Market Broken Down By Segment Categories?
The fluorescent in situ hybridization probe market covered in this report is segmented –
1) By Type: Deoxyribonucleic Acid (DNA) Probes, Ribonucleic Acid (RNA) Probes, Multiplex Probes
2) By Target: Genes, Chromosomes, Other Targets
3) By Technology: Single-Color Fluorescence In Situ Hybridization (FISH), Multiplex Fluorescence In Situ Hybridization (FISH), Quantitative Fluorescence In Situ Hybridization (FISH), Others Technologies
4) By Application: Clinical Diagnostics, Research Applications, Agricultural Biotechnology, Pharmaceutical Research, Genetic Research
5) By End User: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Companies
Subsegments:
1) By Deoxyribonucleic Acid (DNA) Probes: Centromeric Probes, Telomeric Probes, Whole Chromosome Paint Probes, Locus-Specific Identifier (LSI) Probes, Comparative Genomic Hybridization (CGH) Probes, Gene Fusion Probes
2) By Ribonucleic Acid (RNA) Probes: mRNA Probes, Long Non-Coding RNA (lncRNA) Probes, MicroRNA (miRNA) Probes, Single-Molecule RNA FISH Probes (smFISH), Circular RNA (circRNA) Probes, Multiplexed Error-Robust FISH (MERFISH) Probes
3) By Multiplex Probes: Multicolor DNA FISH Probes, Multigene Expression Analysis Probes, High-Throughput Screening Probes, Multiplex smFISH Probes, Combinatorial Barcoded Probes, Simultaneous DNA/RNA Detection Probes
Which Trends Are Shaping Growth In The Fluorescent In Situ Hybridization Probe Market?
Leading companies within the fluorescent in situ hybridization probe market are increasingly prioritizing the formation of strategic collaborations. These partnerships aim to facilitate access to new markets, advanced technologies, or specialized expertise that might otherwise be difficult or costly to develop independently. A strategic collaboration typically involves a planned alliance between two or more entities combining their strengths and resources to achieve common long-term objectives and mutual advantages. For example, in April 2025, Empire Genomics, a US-based molecular diagnostics company, partnered with BioDot, a US-based provider of precision dispensing automation, to introduce the BDot Probe Line. This new line offers a distinct solution by providing FISH probes that are pre-optimized for automated systems, addressing a critical challenge in clinical cytogenetics and molecular pathology laboratories. These probes are engineered for direct application without requiring manual adjustments, ensuring smooth operation with the Biodot CellWriter S system. This innovation reduces the need for technician intervention, streamlines workflows, and shortens the time required to obtain results. The initial range of BDot Probe Panels supports FISH analysis for a broad spectrum of blood-related cancers, including MM, MDS, CML, AML, ALL, and other common hematologic conditions.
Which Players Are Present In The Fluorescent In Situ Hybridization Probe Market Space?
Major companies operating in the fluorescent in situ hybridization probe market are Thermo Fisher Scientific Inc., Abbott Laboratories, Oxford Gene Technology IP Limited, Sigma-Aldrich Co. LLC, Agilent Technologies Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Leica Biosystems Nussloch GmbH, Biocare Medical LLC, Enzo Biochem Inc., LGC Biosearch Technologies, ZytoVision GmbH, Creative Biolabs Inc., Empire Genomics LLC, MetaSystems GmbH, Abnova Corporation, Mirus Bio LLC, Genemed Biotechnologies Inc., Molecular Instruments Inc., Cytocell Technologies Limited.
Get The Full Fluorescent In Situ Hybridization Probe Market Report:
Which Region Represents The Largest Share Of The Fluorescent In Situ Hybridization Probe Market?
North America was the largest region in the fluorescent in situ hybridization probe market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fluorescent in situ hybridization probe market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Fluorescent In Situ Hybridization Probe Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=27289&type=smp
Browse Through More Reports Similar to the Global Fluorescent In Situ Hybridization Probe Market 2026, By The Business Research Company
Motor Insurance Market Report 2026
https://www.thebusinessresearchcompany.com/report/motor-insurance-global-market-report
Home Insurance Market Report 2026
https://www.thebusinessresearchcompany.com/report/home-insurance-global-market-report
Embedded Insurance Market Report 2026
https://www.thebusinessresearchcompany.com/report/embedded-insurance-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model